LakeShore Biopharma Co., Ltd Warrants (LSBPW)

• Market cap: $3.51M
• 1 day: -31.85%
• 5 days: -31.85%
• 1 month: -45.24%
• 3 months: -51.06%
• 6 months: -60.85%
• Year to date: -81.6%
• 1 year: -73.33%
• 5 years: -87.74%
• 10 years: -87.74%
• Sector: Healthcare
• Industry: Biotechnology

About: LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Employees: 573

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

69% more capital invested

Capital invested by funds: $196K [Q1] → $331K (+$135K) [Q2]

6% more funds holding

Funds holding: 18 [Q1] → 19 (+1) [Q2]

0.55% more ownership

Funds ownership: 2.15% [Q1] → 2.7% (+0.55%) [Q2]

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1